AVBP

ArriVent BioPharma, Inc. Common Stock (AVBP) 10Y Growth Potential Analysis (2026)

Invetso Score: 4.8/10 — Balanced · Last Updated: 2026-08-01

Overall Score

Financial Strength

AVBP shows very strong liquidity with a current ratio of 14.16x and cash ratio of 5.56x.

Leverage remains minimal, with debt-to-equity at 0.001x and debt-to-assets at 0.001x.

Net current asset value of $366.3M and cash per share of $7.84 provide a substantial balance-sheet cushion.

Profitability

Trailing margins are effectively zero, indicating no current operating profitability.

Returns remain deeply negative, including ROA of -41.5%, ROE of -50.3%, and ROIC of -47.9%.

Negative operating cash flow and free cash flow per share of -$3.11 confirm ongoing losses at the cash level.

Growth

No revenue or margin expansion is visible in the trailing data, limiting evidence of durable growth.

The company is still generating negative operating cash flow, which suggests growth is not yet translating into scalable economics.

With no fresh news or updated operating catalysts, there is no new evidence of accelerating demand or product-driven growth.

Valuation

The stock screens as asset-backed rather than earnings-backed, with price-to-book at 3.83x and price-to-fair-value at 3.83x.

Negative earnings and cash flow make conventional earnings and cash-flow multiples less meaningful.

The large cash position and low debt help support the valuation, but the lack of profitability limits upside confidence.

Momentum

There is no recent news flow to indicate improving sentiment or a near-term catalyst.

Trailing financials remain negative, which does not support positive momentum.

Without evidence of operational inflection, momentum remains weak.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on ArriVent BioPharma, Inc. Common Stock. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →